| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35c4274bafe80fe6279f7c22540d6894 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-48 |
| filingDate |
2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349141caa184e9e54f5990707b01bf88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4efed4074afb65fc456ad952b7a2bab6 |
| publicationDate |
2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-0210722-A |
| titleOfInvention |
Biodegradable Injectable Implants and Related Methods of Production and Use |
| abstract |
"BIODEGRADABLE INJECTABLE IMPLANTS AND RELATED PRODUCTION AND USE METHODS". This invention is directed to the field of medical implants, and more specifically to biodegradable injectable implants and their methods of production and use. Injectable implants presented in the present invention comprise glycolic acid and biocompatible / bioabsorbable polymeric particles containing a lactic acid polymer. The particles are small enough to be injected through a needle, but large enough to avoid involvement by macrophages. The injectables of this invention may be in a pre-activated solid form or an activated form (for example, suspension or emulsion for injection). |
| priorityDate |
2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |